UNSPSC 51131805: Etamsylate or ethamsylate

This classification denotes a hemostatic and benzenesulfonate with the molecular formula C6H6O5S.C4H11N, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 24YL531VOH, chemically known as 2,5-dihydroxybenzenesulfonic acid compound with diethylamine (1:1) but more generally known as etamsylate, which bears US NIH Compound Identifier 17506.

European Medicines Agency schedules Etamsylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11943MIG World Health Organization schedules etamsylate in its Anatomical Therapeutic Chemical (ATC) Classification. ETAMSYLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(O)C1C(O)CCC(O)C1.N(CC)CC.

UNSPSC 51131805 Etamsylate or ethamsylate is a Commodity code that covers pharmaceutical hemostatic agents used to control bleeding. State and local governments procure this product primarily through cooperative purchasing vehicles and standing agreements rather than direct solicitations, as the code appears in the recent opportunities dataset in limited volume. Issuing bodies that use this code include state health departments, county public health agencies, school districts maintaining medical supplies, and emergency services departments. The product is typically bundled into broader medical supply or law enforcement equipment purchasing agreements that establish standing inventory or on-call availability for emergency response and routine clinical use.

No recent state or local contract opportunities directly soliciting etamsylate or ethamsylate appear in the current posting activity. The single entry in the recent-opportunities block (Sourcewell RFP #061626, posted May 12, 2026, due June 16, 2026) is a cooperative purchasing vehicle for law enforcement equipment issued by Sourcewell on behalf of multiple Washington counties and other jurisdictions nationwide; etamsylate is not pharmaceutical hemostatic agents and does not align with the law enforcement equipment scope. This code shows minimal standalone procurement activity at the state and local level in the current market, suggesting that pharmaceutical hemostatics are either incorporated into broader medical supply contracts under higher-tier UNSPSC families, acquired through national cooperative agreements, or sourced through hospital pharmacy systems rather than traditional competitive procurement.